The First FDA-Approved Digital Pill — What It Means For Pharma Harsha Madannavar Justin Wang Helen Chen Read more
Related Practice Life Sciences & Pharma In mid-November 2017, the U.S. FDA approved Japan-based Otsuka Pharmaceutical’s Abilify MyCite— a first for digital medicine. 07312019140709
Executive Insights Life Sciences & Pharma When Is It Too Late? Drivers of Commercial Performance for Late Entrants in Biopharma April 28, 2025
Executive Insights Life Sciences & Pharma The Future of Animal Health: Strategic Lessons from Human Healthcare March 17, 2025
Executive Insights Telehealth and Digital Transformation Healing Bytes: A Prescription for Commercializing Healthcare Data in Asia and the Middle… October 23, 2024
Published Articles Data & Analytics Use Data and Analytics to Create Your Strategy, Not Just Drive It: Why Critical Decisions… July 23, 2024
Article Life Sciences & Pharma Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors July 2, 2024